Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

Executive Summary

Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.

You may also be interested in...



US FDA Succession Question Looms For Biden Administration As Hahn Departure Nears

As is tradition, political appointments offer resignations when a new administration takes office. The incoming president can ask them to stay but often they are let go. Commissioner Hahn is expected to be among the many Trump administration agency heads who will depart.

US FDA Faces Succession Questions As Hahn’s Departure Nears

Plan specifying the acting head of FDA until new commissioner is confirmed references senior positions that no longer exist.

Giroir Becomes Acting US FDA Commissioner, Giving Agency Experienced Political Hand

Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel